U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Dyslipoproteinemias

MedGen UID:
108970
•Concept ID:
C0598784
•
Pathologic Function
Synonym: Dyslipoproteinemia

Professional guidelines

PubMed

Diagnosis and management of familial dyslipoproteinemias.
Kwiterovich PO Jr
Curr Cardiol Rep 2013 Jun;15(6):371. doi: 10.1007/s11886-013-0371-5. PMID: 23666884
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
Sniderman A, Couture P, de Graaf J
Nat Rev Endocrinol 2010 Jun;6(6):335-46. Epub 2010 Apr 27 doi: 10.1038/nrendo.2010.50. PMID: 20421882
Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
CMAJ 1990 Jun 15;142(12):1371-82. PMID: 2190685Free PMC Article

Recent clinical studies

Etiology

Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk.
Glavinovic T, Thanassoulis G, de Graaf J, Couture P, Hegele RA, Sniderman AD
J Am Heart Assoc 2022 Oct 18;11(20):e025858. Epub 2022 Oct 10 doi: 10.1161/JAHA.122.025858. PMID: 36216435Free PMC Article
Update on the laboratory investigation of dyslipidemias.
Ramasamy I
Clin Chim Acta 2018 Apr;479:103-125. Epub 2018 Jan 11 doi: 10.1016/j.cca.2018.01.015. PMID: 29336935
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
Sniderman A, Couture P, de Graaf J
Nat Rev Endocrinol 2010 Jun;6(6):335-46. Epub 2010 Apr 27 doi: 10.1038/nrendo.2010.50. PMID: 20421882
Diabetes, exercise, and atherosclerosis.
Ruderman NB, Schneider SH
Diabetes Care 1992 Nov;15(11):1787-93. doi: 10.2337/diacare.15.11.1787. PMID: 1468316
Risks for hyperlipidemia.
Nestruck AC, Davignon J
Cardiol Clin 1986 Feb;4(1):47-56. PMID: 2871933

Diagnosis

Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk.
Glavinovic T, Thanassoulis G, de Graaf J, Couture P, Hegele RA, Sniderman AD
J Am Heart Assoc 2022 Oct 18;11(20):e025858. Epub 2022 Oct 10 doi: 10.1161/JAHA.122.025858. PMID: 36216435Free PMC Article
ApoB in clinical care: Pro and Con.
Sniderman AD, Robinson JG
Atherosclerosis 2019 Mar;282:169-175. Epub 2018 Nov 10 doi: 10.1016/j.atherosclerosis.2018.11.001. PMID: 30463677
Update on the laboratory investigation of dyslipidemias.
Ramasamy I
Clin Chim Acta 2018 Apr;479:103-125. Epub 2018 Jan 11 doi: 10.1016/j.cca.2018.01.015. PMID: 29336935
Diagnosis and management of familial dyslipoproteinemias.
Kwiterovich PO Jr
Curr Cardiol Rep 2013 Jun;15(6):371. doi: 10.1007/s11886-013-0371-5. PMID: 23666884
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
Sniderman A, Couture P, de Graaf J
Nat Rev Endocrinol 2010 Jun;6(6):335-46. Epub 2010 Apr 27 doi: 10.1038/nrendo.2010.50. PMID: 20421882

Therapy

ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.
de Nijs T, Sniderman A, de Graaf J
Crit Rev Clin Lab Sci 2013 Nov;50(6):163-71. doi: 10.3109/10408363.2013.847897. PMID: 24295059
Beyond LDL-cholesterol: HDL-cholesterol as a target for atherosclerosis prevention.
Parhofer KG
Exp Clin Endocrinol Diabetes 2005 Sep;113(8):414-7. doi: 10.1055/s-2005-865940. PMID: 16151973
Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm.
Sniderman AD
Curr Opin Lipidol 2004 Aug;15(4):433-8. doi: 10.1097/01.mol.0000137220.39031.3b. PMID: 15243216
Acquired hyperlipidemia (secondary dyslipoproteinemias).
Chait A, Brunzell JD
Endocrinol Metab Clin North Am 1990 Jun;19(2):259-78. PMID: 2192873
Risks for hyperlipidemia.
Nestruck AC, Davignon J
Cardiol Clin 1986 Feb;4(1):47-56. PMID: 2871933

Prognosis

Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk.
Glavinovic T, Thanassoulis G, de Graaf J, Couture P, Hegele RA, Sniderman AD
J Am Heart Assoc 2022 Oct 18;11(20):e025858. Epub 2022 Oct 10 doi: 10.1161/JAHA.122.025858. PMID: 36216435Free PMC Article
A new phenotypic classification system for dyslipidemias based on the standard lipid panel.
Sampson M, Ballout RA, Soffer D, Wolska A, Wilson S, Meeusen J, Donato LJ, Fatica E, Otvos JD, Brinton EA, Rosenson RS, Wilson P, Amar M, Shamburek R, Karathanasis SK, Remaley AT
Lipids Health Dis 2021 Nov 27;20(1):170. doi: 10.1186/s12944-021-01585-8. PMID: 34838008Free PMC Article
Update on the laboratory investigation of dyslipidemias.
Ramasamy I
Clin Chim Acta 2018 Apr;479:103-125. Epub 2018 Jan 11 doi: 10.1016/j.cca.2018.01.015. PMID: 29336935
ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.
de Nijs T, Sniderman A, de Graaf J
Crit Rev Clin Lab Sci 2013 Nov;50(6):163-71. doi: 10.3109/10408363.2013.847897. PMID: 24295059
Application and validation of a diagnostic algorithm for the atherogenic apoB dyslipoproteinemias: ApoB dyslipoproteinemias in a Dutch population-based study.
Holewijn S, Sniderman AD, den Heijer M, Swinkels DW, Stalenhoef AF, de Graaf J
Eur J Clin Invest 2011 Apr;41(4):423-33. Epub 2010 Dec 3 doi: 10.1111/j.1365-2362.2010.02426.x. PMID: 21128932

Clinical prediction guides

Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk.
Glavinovic T, Thanassoulis G, de Graaf J, Couture P, Hegele RA, Sniderman AD
J Am Heart Assoc 2022 Oct 18;11(20):e025858. Epub 2022 Oct 10 doi: 10.1161/JAHA.122.025858. PMID: 36216435Free PMC Article
Update on the laboratory investigation of dyslipidemias.
Ramasamy I
Clin Chim Acta 2018 Apr;479:103-125. Epub 2018 Jan 11 doi: 10.1016/j.cca.2018.01.015. PMID: 29336935
Application and validation of a diagnostic algorithm for the atherogenic apoB dyslipoproteinemias: ApoB dyslipoproteinemias in a Dutch population-based study.
Holewijn S, Sniderman AD, den Heijer M, Swinkels DW, Stalenhoef AF, de Graaf J
Eur J Clin Invest 2011 Apr;41(4):423-33. Epub 2010 Dec 3 doi: 10.1111/j.1365-2362.2010.02426.x. PMID: 21128932
Dyslipoproteinemias in diabetes.
Steiner G
Clin Invest Med 1995 Aug;18(4):282-7. PMID: 8549014
Abdominal obesity as important component of insulin-resistance syndrome.
Després JP
Nutrition 1993 Sep-Oct;9(5):452-9. PMID: 8286886

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • MeSH
      Related Medical Subject Headings
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...